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Abstract
Calpains are calcium regulated cysteine proteases that have been described in a wide range of cellular processes, including
apoptosis, migration and cell cycle regulation. In addition, calpains have been implicated in differentiation, but their impact
on neural differentiation requires further investigation. Here, we addressed the role of calpain 1 and calpain 2 in neural stem
cell (NSC) self-renewal and differentiation. We found that calpain inhibition using either the chemical inhibitor calpeptin or
the endogenous calpain inhibitor calpastatin favored differentiation of NSCs. This effect was associated with significant
changes in cell cycle-related proteins and may be regulated by calcium. Interestingly, calpain 1 and calpain 2 were found to
play distinct roles in NSC fate decision. Calpain 1 expression levels were higher in self-renewing NSC and decreased with
differentiation, while calpain 2 increased throughout differentiation. In addition, calpain 1 silencing resulted in increased
levels of both neuronal and glial markers, b-III Tubulin and glial fibrillary acidic protein (GFAP). Calpain 2 silencing elicited
decreased levels of GFAP. These results support a role for calpain 1 in repressing differentiation, thus maintaining a
proliferative NSC pool, and suggest that calpain 2 is involved in glial differentiation.
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Introduction
Differentiation is the process by which stem cells give rise to
committed and specialized cells [1]. Stem cells have been
successfully used in regenerative medicine [2,3]. Nevertheless, the
potential of stem cells is yet far from being fully explored and
requires a better understanding of stem cell biology. Neural stem
cells(NSC)havetheabilitytoproliferateandself-renew,aswellasto
differentiate, following induction, into several neural cell types,
including neurons, oligodendrocytes and glial cells [4–6]. Although
thoroughly studied, the molecular pathways regulating differentia-
tion of stem cells are still not fully defined, and may implicate cell
cycle, apoptosis and migration, among other processes.
Calpains are a large conserved family of cysteine proteases
regulated by calcium which cleave many different substrates,
modulating protein activity [7]. Calpains have been implicated in
the regulation of a wide range of cellular processes, including cell
cycle, migration, apoptosis, autophagy and synaptic plasticity [8–
14]. Calpain activity can be modulated by calcium and
phospholipid binding, phosphorylation, autolysis and subcellular
localization [7,15,16]. Additionally, calpains are regulated by the
specific endogenous inhibitor calpastatin [17]. Unlike other
proteases, calpains do not have a consensus substrate-binding or
cleavage site, making it difficult to predict their possible substrates.
In fact, substrates cleaved by different calpains vary depending on
the context, probably as a consequence of the complex regulatory
network affecting these proteases. Calpain 1 and calpain 2 are the
most studied and abundant calpain molecules in the brain [8].
Although calpains have several important physiological func-
tions, most of the studies involving these proteases in the central
nervous system are disease-related. In fact, calpains have been
implicated in several brain pathologies, such as Parkinson’s
disease, Alzheimer’s disease, Huntington’s disease, stroke and
brain trauma [8,18,19]. The importance of calpains in synaptic
function and memory formation has also been studied [8,9].
Several studies have implicated calpains in differentiation
mechanisms, including differentiation of mesenchymal stem cells,
such as myoblasts, osteoblasts, chondrocytes and adipocytes [20]. A
role for cysteine proteases in differentiation of embryonic stem cells
into neural cells has alsobeen reported, although the involvement of
calpains in embryonic stem cell differentiation was argued against
[21]. Nevertheless, neural progenitor cells exhibit calcium transients
during cell cycle progression that are required for proliferation in
cellular models [22]. In addition, mitogen-activated protein kinase
(MAPK) and phosphatidylinositol-3 kinase (PI3K)/Akt are major
signaling pathways implicated in a wide range of cellular processes
[23,24], including neural stem cell proliferation and differentiation
[25–29]. These pathways have previously been implicated in
regulation of calpain activity [15,16,30,31]. Interestingly, calpain
and calpastatin activities are modulated during neural differentia-
tion of rat pheochromocytoma (PC12) cells [32–34]. Altered
expressions levels for both calpain and calpastatin proteins were
also described during human neuroblastoma cell differentiation to
Schwann and neuronal cells [35]. Nevertheless, the potential
function of calpains during neural differentiation is still poorly
understood and requires further investigation.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33468In the present study, we elucidated the role of calpain 1 and 2
during NSC self-renewal and differentiation. Our results suggest
that calpain 1 maintains stemness and represses neural differen-
tiation. In addition, calpain 2 acts as potential modulator of
gliogenesis. These results underscore the distinct regulatory
functions of calpain 1 and 2 in NSC fate decision.
Results
Calpain inhibition decreases proliferation of neural stem
cells
Although calpains have already been implicated in several
differentiation systems [20,32–34], their involvement during
neural differentiation has not yet been fully explored. We have
previously shown that cysteine proteases, such as caspases, regulate
mouse NSC differentiation by interfering with the FOXO3A/Id1
signaling pathway [36].
To address the role of calpains in NSC self-renewal and
differentiation, we first incubated NS-TGFP cells with the calpain
chemical inhibitor calpeptin in permissive condition medium. This
specific condition maintains cells in a proliferative status, although
low levels of differentiation can be observed after a few days in
culture. After 24 h, cells were treated with 50 mM calpeptin or
dimethyl sulfoxide (DMSO; control) and incubated for additional
6, 9 or 27 h. Our results show that calpeptin treatment resulted in
a marked decrease in cell number, eliciting almost 50% reduction
in cell density at 27 h (p,0.01) (Figure 1A). However, this did not
correlate with increased cell death, as measured by propidium
iodide (PI) and Annexin-V staining, indicating low levels of toxicity
(Figure 1B). Bromodeoxyuridine (BrdU) incorporation, in turn,
revealed a 25% decrease in proliferation after calpeptin treatment,
as assessed by immunocytochemistry (Figure 1C) and flow
cytometry (Figure 1D) analysis (p,0.01).
To investigate whether inhibition of proliferation by calpains
was due to altered cell cycle dynamics, we investigated the
expression levels of several cell cycle markers. Interestingly,
truncated p27 was decreased after calpeptin treatment of NS-
TGFP cells (Figure 2). Truncation of cyclin-dependent kinase
inhibitor p27 results in a substantial reduction in its inhibitory
activity [37,38]. In addition, calpain inhibition increased p21 and
decreased cyclin E levels, indicative of impaired G1 progression in
these conditions [39]. Our results suggest that calpain activity is
involved in cell cycle progression and proliferation of NSC.
Calpain inhibition increases differentiation of NSC
Cell cycle dynamics can influence differentiation, including
neurogenesis [39,40]. We next investigated the differentiation status
of calpeptin-treated NS-TGFP cells. Interestingly, calpeptin treat-
ment decreased the proportion of Nestin-positive cells by ,35%
(p,0.05) (Figure 3A), while increasing the percentage of b-III
Tubulin-positive by almost 90% (p,0.001) (Figure 3B), indicating
loss of stemness and induction of neural differentiation, respectively.
Similar results were obtained in a mouse neurosphere model
(MNSC). Calpeptin-treated MNSC showed a 15% decrease in the
proportion of Nestin-positive cells (p,0.05) and a 45% increase in
the percentage of b-III Tubulin-positive cells (p,0.05) (Figure 3C).
We next sought to determine if any of the MAPK and PI3K/
Akt pathways regulated calpain activity in NSC and if their
inhibition mimicked the effects observed after calpain inhibition by
calpeptin. NS-TGFP cells were treated with p38, extracellular
signal-regulated kinase mitogen-activated protein kinase (MEK/
ERK) and PI3K/Akt chemical inhibitors (SB203580, PD98059
and wortmannin, respectively), and the differentiation status was
evaluated after 24 h (Figure 4A and B). Surprisingly, no significant
differences were seen in the percentage of Nestin- or b-III
Tubulin-positive cells, as compared to the control, indicating that,
in these conditions, neither the MAPK p38 or MEK/ERK
pathways, nor the PI3K/Akt pathway are involved in the calpain-
mediated regulation of self-renewal and differentiation of NSC.
We have also treated NS-TGFP cells with several inhibitors for
calcium receptor/channels, previously shown to maintain calcium
oscillations in NSC [22], namely nifedipine, an L-type channel
blocker; dantrolene, a ryanodine receptor channel antagonist; and
xestospongin C, an inositol trisphosphate receptor (IP3R) inhibitor.
Figure 1. Calpeptin treatment decreases cell density and
proliferation. NS-TGFP cells were cultured in permissive conditions
and treated with either 50 mM calpeptin or DMSO (control), and BrdU
was added 3 h later as described in Materials and Methods.( A) Cell
density was accessed at different times after treatment and calculated
as the number of live cells per cm
2 dish surface area. (B) Cell viability
was determined by flow cytometry after 24 h and expressed as the
percentage of PI and Annexin-V double-negative cells. (C) Immunocy-
tochemistry detection of BrdU-positive nuclei (brown). (D) Representa-
tive histogram of BrdU positive cells assessed by flow cytometry (left),
and respective quantification data (right). Data represent mean 6 SEM
of three independent experiments. 1p,0.05 and *p,0.01 from
respective control.
doi:10.1371/journal.pone.0033468.g001
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both nifedipine and xestospongin C treatment resulted in differences
similar to calpeptin treatment (Figure 4A and B). In fact, nifedipine
and xestospongin C induced a small, but significant decrease in the
percentage of Nestin-positive cells (p,0.01 and p,0.001, respec-
tively), and a marked increase in the proportion of b-III Tubulin-
positive cells (p,0.001 and p,0.05, respectively). Thus, our results
suggest that calcium oscillations mediated by IP3R and L-type
channels are responsible for calpain activation, maintenance of self-
renewal and repression of differentiation of NSC.
Calpain inhibition throughout neural differentiation
increases neurogenesis
To further explore the mechanism by which calpains regulate
neural differentiation, we transfected NS-TGFP cells with
calpastatin, an endogenous specific calpain inhibitor [17], and
then induced neural differentiation. Cells were grown under
differentiation conditions for 48 h and the expression of neuronal
and glial differentiation markers b-III Tubulin and glial fibrillary
acidic protein (GFAP) was accessed at several time-points. As
expected, both neural markers increased throughout differentia-
tion, starting at 24 h and peaking at 48 h (Figure 5A). Cells
developed typical neuronal and astrocytic morphologies, accom-
panied by the expression of b-III Tubulin and GFAP, respectively,
at 2 days (data not shown) and 4 days in culture (Figure 5B).
Following transfection, the Flag-calpastatin construct was easily
detected by Western blot 24 h after induction of differentiation
(Figure 6A). More importantly, calpastatin overexpression in-
creased b-III Tubulin expression by 40% (p,0.05) (Figure 6B),
corroborating our previous observation in calpeptin-treated NSC.
However, no differences in GFAP levels were detected. Thus, our
results reinforce the role of calpains in NSC fate and indicate that
calpains may differently modulate neurogenesis and gliogenesis.
Calpain 1 and 2 are differentially expressed throughout
neural differentiation and do not correlate with cell death
Calpain 1 and 2 are the most abundant calpain molecules in the
brain [8], and calpastatin inhibits the activity of both proteins [17].
We next addressed their specific contributions to neural
differentiation. Curiously, expression levels of calpain 1 were
markedly higher in self-renewing NSC, and decreased significantly
during differentiation of NS-TGFP cells (Figure 7A). In contrast,
calpain 2 increased throughout differentiation in a similar manner
as b-III Tubulin and GFAP. In MNSC, b-III Tubulin- and GFAP-
positive cells have previously been detected at 3 and 8 days of
differentiation, respectively [36]. Accordingly, the expression
patterns of both calpain 1 and 2 were similar to those found in
NS-TGFP undergoing differentiation, with levels of calpain 1
decreasing as calpain 2 increased throughout neural differentiation
(Figure 7B). Thus, our results suggest that calpain 1 and 2 have
distinct functions throughout NSC differentiation. Finally, as
calpains are apoptosis-associated proteases, we searched for a
correlation between calpain expression and cell death throughout
differentiation. We have previously shown that differentiation of
MNSC was not associated with an increase in cell death [41].
Similarly, our results reveal no significant differences in viability
and cell death of differentiating NS-TGFP cells, as measured by PI
and Annexin-V staining (Figure 7C). These results indicate that
calpains may be important for the regulation of neural
differentiation in a cell death-independent manner.
Calpain 1 represses neural differentiation, while calpain 2
increases glial differentiation
To further investigate the precise roles of calpain 1 and 2 during
neural differentiation, we transfected NS-TGPF cells with siRNA
specific for calpain 1 (siCAPN1) or calpain 2 (siCAPN2), or
unspecific control, and then induced differentiation. Reduced
expression of calpain 1 and 2 was observed by Western blot in cells
treated with siCAPN1 and siCAPN2, respectively (Figure 8A).
Both b-III Tubulin and GFAP expression levels were ,25%
(p,0.05) and 50% (p,0.01) increased after calpain 1 silencing
(Figure 8B). Calpain 2 knockdown, in turn, elicited a significant
decrease in GFAP expression (p,0.05), but no differences in b-III
Tubulin expression. These results were corroborated by immu-
nocytochemistry analysis (Figure 8C). The opposing actions of
calpain 1 and 2 on GFAP expression may explain the absence of
Figure 2. Calpeptin treatment modulates cell cycle proteins. NS-TGFP cells were cultured in permissive conditions, treated with either 50 mM
calpeptin or DMSO (control) for 24 h and processed for immunoblotting as described in Materials and Methods. Representative immunoblots (top)
and corresponding densitometry analysis (bottom) of cyclin E, p21 and p27 levels after calpeptin treatment. Two distinct p27 bands were detected,
corresponding to full length (,27 kDa) and truncated (marked with *) forms. Data represent mean 6 SEM of three independent experiments.
1p,0.05 and {p,0.001 from respective control.
doi:10.1371/journal.pone.0033468.g002
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Thus, our results suggest that calpain 1 plays a role in cell cycle
progression of NSC, delaying differentiation and maintaining a
proliferative neural stem cell pool, while calpain 2 may be
important for glial differentiation.
Discussion
The present study identifies a distinct regulatory function of
calpains during NSC proliferation and differentiation in vitro.
Figure 3. Calpeptin treatment decreases Nestin- and increases
b-III Tubulin-positive cells. NS-TGFP cells and MNSC were cultured in
permissive or differentiation conditions, respectively, treated with either
50 mM calpeptin or DMSO (control), and collected after 24 or 48 h as
described in Materials and Methods. Cells were subsequently labeled for
Nestin and b-III Tubulin detection by flow cytometry as described in
Materials and Methods.( A) Representative histogram of Nestin-positive
cells (left) and respective quantification data (right) in NS-TGFP cells
after 24 h. (B) Representative histogram of b-III Tubulin-positive cells
(left) and respective quantification data (right) in NS-TGFP cells after
24 h. (C) Quantification of Nestin- and b-III Tubulin-positive cells in
MNSC after 24 or 48 h, respectively. Data represent mean 6 SEM of at
least three independent experiments. 1p,0.05 and {p,0.001 from
respective control.
doi:10.1371/journal.pone.0033468.g003
Figure 4. Inhibition of calcium flux decreases Nestin- and
increases b-III Tubulin-positive cells. NS-TGFP cells were cultured
in permissive conditions and treated with either 10 mM SB203580,
20 mM PD98059, 250 nM wortmannin, 20 mM nifedipine, 10 mM
dantrolene, 1 mM xestospongin C or DMSO (control), and collected
after 24 h. Cells were subsequently labeled for Nestin and b-III Tubulin
detection by flow cytometry as described in Materials and Methods.( A)
Quantification of Nestin-positive cells in NS-TGFP cells after different
treatments. (B) Quantification of b-III Tubulin-positice cells. Data
represent mean 6 SEM of at least three independent experiments.
1p,0.05, *p,0.01 and {p,0.001 from respective control.
doi:10.1371/journal.pone.0033468.g004
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calpain 2 is associated with glial differentiation.
Transplantation of stem cells may provide a more permanent
remedy than present drug treatments for cell replacement in
various neurodegenerative diseases. However, stem cells survive
and differentiate poorly after transplantation [42,43]. Curiously, it
has been shown that several conserved elements of apoptosis are
also integral components of terminal differentiation [44,45],
suggesting that apoptosis-related proteins might be important
players of cell fate decisions. We have recently demonstrated the
involvement of specific apoptosis-associated molecules in mouse
NSC differentiation. In fact, apoptosis-associated miRNAs were
involved in neural differentiation [41], and caspase inhibition and
p53 silencing synergistically delayed neural differentiation, with no
evidence of apoptosis [36]. Here, we investigated the potential role
of proteases such as calpains in the regulation of NSC self-renewal
and differentiation.
Much like caspases, calpains are cysteine proteinases that once
activated cleave a wide range of cellular substrates [7]. Calpains
are regulated by calcium and several studies have already
Figure 5. Neuronal and astrocytic phenotypes after induction of neural differentiation. b-III Tubulin and GFAP expression was evaluated
in NS-TGFP cells at different times of differentiation as described in Materials and Methods.( A) Representative immunoblots (top) and corresponding
densitometry analysis (bottom) showing an increase in b-III Tubulin and GFAP protein levels throughout neural differentiation. Results are expressed
as mean 6 SEM arbitrary units for at least three independent experiments. 1p,0.05 and {p,0.001 from undifferentiated cells. (B)
Immunofluorescence detection of neuronal and astrocytic morphology in cells co-stained with anti-b-III Tubulin and anti-GFAP antibodies after 4
days of neural differentiation. Scale bar, 20 mm.
doi:10.1371/journal.pone.0033468.g005
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supporting the idea that apoptosis-associated factors are involved
in regulation of the differentiation process. In fact, it has been
demonstrated that during muscle cell differentiation, calpains
relocate to the cell membrane of myoblasts in response to calcium
flux and participate in fusion associated protein degradation
[46,47]. Calpains have also been implicated in osteoblast and
chondrocyte differentiation [20], as well as in the turnover of
transcriptional nuclear proteins driving differentiation of 3T3-L1
preadipocytes [48,49]. However, calpain activation has not always
been associated with promotion of cellular differentiation. The
conversion of ST-13 preadipocytes into adipocytes was shown to
be enhanced by calpain inhibition [20]. The specific role of
calpains during neural differentiation remains largely unknown
and requires further investigation, as only a few studies were
performed in appropriate cell models [32–35].
In the present study, we first demonstrated that treatment of
NS-TGFP mouse NSC with the calpain chemical inhibitor
calpeptin decreases both cell number and proliferation. Our data
is in accordance with other studies highlighting the importance of
calpain activity in cell cycle progression, particularly in the
transition from G1 to S phase [50–53]. We show that inhibition of
calpain activity in NSC by calpeptin leads to a significant decrease
in cyclin E levels, responsible for the G1/S transition. The
impairment of cell cycle progression induced by calpeptin was also
detected by p21 accumulation and decreased p27 degradation,
evidenced by the presence of a lower molecular weight truncated
fragment [38]. In fact, it has already been shown that deletion of
calpain regulatory small subunit Capn4 results in impaired cell
cycle progression in chondrocytes. This specific deletion led to an
accumulation of certain cell cycle proteins known as calpain
substrates, such as cyclin D, cyclin E, and p27, as well as reduced
phosphorylation of retinoblastoma protein and p27 [50]. p27
transcription and degradation, in turn, was also shown to be
mediated by calpains in other models, including osteoblasts,
cortical neurons and preadipocytes [51–53]. Further, p21
accumulation induced by calpain inhibition has also been
observed in other studies, where in vitro incubation with calpain
1 and 2 resulted in rapid degradation of p21 [54,55]. It has been
demonstrated that calcium oscillations occurring in G1 to S
transition are required for cell cycle progression in both neural
progenitor and undifferentiated cells, correlating with G1
shortening and increased proliferation [22,56]. Furthermore,
calcium oscillations increase the levels of several proliferation-
associated proteins and decrease p27-mediated inhibition [22].
Curiously, it was recently proposed that the length of G1 directly
influences the differentiation rate of neural precursors [39,56,57].
In this respect, it appears that G1 phase prolongation is both
necessary and sufficient to induce switching from proliferation to
differentiation in neural progenitors [39]. Therefore, it is not
surprising that calpains accelerate G1 to S transition and that
calpain inhibition is necessary to increase G1 length and promote
neural stem cell differentiation. Consistent with this hypothesis,
our results revealed that treatment of neural stem cells with
calpeptin induces a significant decrease in the proportion of
Nestin-positive neural progenitors, while increasing the proportion
of neuronal cells positive for b-III Tubulin. These results were also
obtained in MNSC cultures, revealing that NSC differentiation
induced by calpain inhibition was not restricted to the NS-TGFP
cell line. To clarify the specific signaling pathway that regulate
calpain activity in NSC, NS-TGFP cells were treated with different
chemical inhibitors of major signaling pathways. Our results
showed that, similarly to calpeptin treatment, inhibition of calcium
flux strongly influences NSC fate decision. We tested the IP3R, L-
type channel and ryanodine receptor inhibitors xestospongin C,
nifedipine, and dantrolene, respectively, and observed that the first
two had a significant effect in NSC differentiation, decreasing
Nestin and increasing b-III Tubulin positive cells in the
population. In fact, it has already been shown that calcium
oscillations in neural progenitor cells are restricted to the G1/S
transition and require calcium influx only through IP3Rs, L-type
channels and ryanodine receptors [22]. Since calpains are
calcium-activated proteases, it is possible that calpains are
regulated by calcium oscillations in G1, thereby promoting cell
cycle progression through modulation of cell cycle proteins.
To further address the role of calpains during neural
differentiation, the expression levels of specific calpain 1 and 2
were investigated and found to be strikingly different throughout
NSC differentiation. In fact, while calpain 1 expression was higher
during self-renewal and decreased throughout differentiation,
expression of calpain 2 markedly increased during neural
differentiation in both NS-TGFP and MNSC. More importantly,
fluctuations in calpain expression are not associated with cell-death
signaling pathways, as no difference was detected in cell viability
throughout differentiation in both cell models. Thus, our
observation raises the possibility that calpain 1 and 2 differentially
regulate NSC biology. The fact that calpain 1 is mostly expressed
in self-renewing NSC suggests its involvement in regulation of
Figure 6. Calpastatin overexpression increases neuronal but
not glial differentiation. b-III Tubulin and GFAP expression levels
were evaluated by immunoblotting in NS-TGFP cells. Cells were
transfected with either pcDNA-Flag-mCAST or pcDNA empty vector
(control), differentiated and collected after 24 h, as described in
Materials and Methods.( A) Representative immunoblots of Flag
expression and b-actin in control and calpastatin overexpressing cells.
(B) Representative immunoblots (top) and corresponding densitometry
analysis (bottom) showing increased b-III Tubulin expression (left) and
unchanged GFAP (right) protein levels in pcDNA-Flag-mCAST transfect-
ed cells. b-actin was used as loading control. Results are expressed as
mean 6 SEM arbitrary units for six independent experiments. *p,0.01
from control.
doi:10.1371/journal.pone.0033468.g006
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calpains have already been reported. Calpain 1, but not calpain 2,
was shown to be present in the nucleus and cytoplasm of cultured
cortical neurons, being capable of degrading p27 in cell lysates
[52]. In addition, calpain 1 degraded the G1 cyclin dependent
kinase inhibitor p19
INK4d in vitro [58], consistent with a role in the
regulation of cellular self-renewal. Notably, our data validates this
hypothesis by showing that calpain 1 silencing increases both
neuronal and glial differentiation.
In this study, calpain 2 levels increased throughout neural
differentiation, suggesting that this specific calpain plays a role
later in differentiation. Accordingly, studies on PC12 neuronal
differentiation have demonstrated that although calpain inhibition
is important in early events of the differentiation process, calpains
may be required in later stages as well [32,34]. In fact, calpastatin
levels declined later during differentiation in a caspase-1
dependent manner, allowing calpain-mediated cleavage of fodrin
[34]. Our results showed that calpain 2 silencing elicited a
Figure 7. Calpain expression levels are altered throughout differentiation of NSC. NS-TGFP and MNSC were grown under differentiation
conditions and collected for calpain 1 and 2 immunoblotting or stained with Annexin-V-APC/PI to evaluate cell death as described in Materials and
Methods.( A) Representative immunoblots (top) and corresponding densitometry analysis (bottom) of calpain 1 and calpain 2 protein levels
throughout NS-TGFP differentiation. b-actin was used as loading control. Results are expressed as the mean 6 SEM arbitrary units for four
independent experiments. 1p,0.05, *p,0.01 and {p,0.001 from undifferentiated cells. (B) Representative immunoblots of calpain 1 and 2
expression throughout MNSC differentiation. Ponceau staining was used as loading control. (C) Representative Annexin-V-APC/PI data plot (left) and
quantification data of viable (PI-negative, Annexin-V-negative) cells (right), showing absence of cell death throughout NS-TGFP differentiation. Data
represent mean 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0033468.g007
Regulation of Neural Differentiation by Calpains
PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33468Regulation of Neural Differentiation by Calpains
PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33468significant decrease in GFAP expression during neural differen-
tiation, while no significant differences were detected in b-III
Tubulin expression. This finding, coupled with others showing
that calpain 2 is mostly localized in glial cells, while calpain 1 is
located primarily in neurons [52,59,60], suggests that calpain 2
activity is important for glial, but not neuronal differentiation. In
fact, the inhibition of both calpains during neural differentiation
by calpastatin resulted in a marked increase in b-III Tubulin
expression and no differences in GFAP levels. If calpain 1 is indeed
responsible for maintaining NSC self-renewal, it would be
expected that its inhibition would induce a significant increase in
both b-III Tubulin and GFAP, as detected after calpain 1
silencing. However, it is not surprising that GFAP levels remained
unchanged after calpastatin treatment if we consider that
inhibition of calpain 2 leads to decreased GFAP expression. Thus,
calpain regulation of neural stem cell fate choices is apparently a
complex process that may involve a tightly coordinated action of
different calpains during self-renewal and differentiation stages.
Collectively, our results support a role for calpain 1 in the
maintenance of a proliferative neural stem cell pool, and suggest
that calpain 2 is involved in the onset of glial differentiation.
Further insight into the factors regulating calpain 1 and 2 activities
and their specific substrates during neural differentiation is
necessary to understand the complexity of calpain function in
NSC fate decision.
Materials and Methods
Ethics statement
The embryonic stem-derived mouse NSC line, a Tau- green
fluorescent protein cell line (NS-TGFP) was obtained from Dr.
Smith’s Laboratory, University of Cambridge, Cambridge, UK
[61], and provided by Dr. Henrique, University of Lisbon, Lisbon,
Portugal. Neurospheres of MNSC were obtained from Dr.
Reynold’s Laboratory, University of Queensland, Brisbane,
Australia, and provided by Dr. Low, University of Minnesota,
Minneapolis, MN, USA. The Animal Ethical Committee at the
Faculty of Pharmacy, University of Lisbon, Portugal waived the
need for approval.
Cell culture and treatments
NS-TGFP cells were derived from 14.5-days post coitum mouse
fetal forebrain, and constitutively express the fusion protein Tau-
GFP [61,62]. This cell line was established using a method that
produces pure cultures of adherent NSC, which continuously
expand by symmetrical division and are capable of tripotential
differentiation [63–65].NS-TGFP cellsweregrowninmonolayeras
previously described [66] and routinely maintained in undiffer-
entiation medium, Euromed-N medium (EuroClone S.p.A., Pavia,
Italy), supplemented with 1% N-2 supplement (Invitrogen Corp.,
Grand Island, NY), 20 ng/mL epidermal growth factor (EGF;
PeproTech EC, London, UK), 20 ng/mL basic fibroblast growth
factor (bFGF; PeproTech EC) and 1% penicillin-streptomycin
(Invitrogen Corp.), in uncoated tissue culture plastic flasks at 37uC
in a humidified atmosphere of 5% CO2. Medium was changed
every 3 days and cells collected with accutase (Sigma-Aldrich Co.,
St. Louis, MO) when confluent. Permissive conditions were
obtained by platting NSC in tissue culture plates pre-coated with
0.1% gelatin (Sigma-Aldrich Co.) at 3610
4 cells/cm
2 in N2B27
medium, 1:1 mixture of DMEM/F12 (Invitrogen Corp.) and
Neurobasal (Invitrogen Corp.), supplemented with 0.5% N-2
supplement, 1% B27 supplement (Invitrogen Corp.) and 2 mM
L-Glutamine (Invitrogen Corp.). N2B27 medium was further
supplemented with 10 ng/mL EGF, 10 ng/mL bFGF and 1%
penicillin-streptomycin. After 24 h in permissive conditions, 50 mM
calpeptin (Tocris Bioscience, Bristol, UK), 10 mM SB203580
(Tocris Bioscience), 25 mM PD98059, 250 nM wortmannin,
20 mM nifedipine, 10 mM dantrolene, 1 mM xestospongin C or
DMSO (all from Sigma-Aldrich Co.) were added to the culture
medium for 6, 9, 24 or 27 h. After collection with accutase, cells
were counted and processed for flow cytometry analysis, BrdU
staining or immunoblotting. Differentiation of NS-TGFP cells was
performed by first platting cells in undifferentiation medium onto
uncoated tissue culture plastic dishes at 3610
4 cells/cm
2 for 24 h,
and changing the culture medium to differentiation medium,
Euromed-N medium supplemented with 10 ng/mL bFGF, 0.5%
N-2 supplement, 1% B27 supplement and 1% penicillin-strepto-
mycin. Cells were collected before medium change (time 0), or
cultured for additional 3, 6, 24 or 48 h, and then collected for cell
death analysis and protein extraction. For microscopic detection of
neuronal and astrocytic morphology and for immunocytochemical
co-labeling of b-III Tubulin and GFAP, cells were fixed at 2 days of
differentiation or 4 days ofdifferentiationin the presence of 1% fetal
bovine serum (FBS) (Invitrogen Corp.) for the last 2 days in culture,
and then processed as described below.
Primary MNSC containing a constitutively expressed marker
for GFP were also used in selected experiments. MNSC were
obtained from central nervous system tissue of embryonic mice
[67–69], maintained as neurospheres and induced to differentiate
as previously described [36,41]. Cells were collected at 1, 2, 3, 6 or
8 days after induction of differentiation and processed for flow
cytometry analysis or immunobloting assays.
siRNA and plasmid transfections
For short interference RNA (siRNA) transfections, two pools of
4 siRNA nucleotides designed to knockdown mouse calpain 1 (L-
062006-00-0005) and calpain 2 (L-043027-00-0005) expression
were purchased from Dharmacon (Waltham, MA). A control
siRNA containing a scrambled sequence that does not lead to the
specific degradation of any known cellular mRNA was used as
control. Briefly, cells were first cultured in uncoated dishes in
undifferentiation medium without penicillin-streptomycin. Twenty
four hours after plating, cells were transfected with 100 nM siRNA
in the presence of 10% FBS using Lipofectamine 2000 (Invitrogen
Corp.), according to the manufacturer’s instructions. Six hours
later, the medium was changed to differentiation medium and cells
were cultured for additional 24 and 48 h. Efficiencies of calpain 1
and calpain 2 silencing were assessed by immunoblotting. Calpain
Figure 8. Calpain 1 and 2 silencing regulates the expression of neural differentiation markers. NS-TGFP cells were transfected with
siRNAs for either calpain 1 (siCAPN1), calpain 2 (siCAPN2) or control siRNA, and then differentiated. Cells were fixed for immunocytochemistry or
collected for Western blot analysis as described in Materials and Methods.( A) Representative immunoblots showing a reduction of calpain 1 (left) and
calpain 2 (right) protein levels after siRNA-induced silencing. (B) Representative immunoblots (top) and corresponding densitometry analysis
(bottom) showing altered b-III Tubulin (left) and GFAP (right) protein levels following calpain 1 or calpain 2 silencing. Results are expressed as mean 6
SEM arbitrary units for at least three independent experiments. b-actin was used as loading control. 1p,0.05 and *p,0.01 from control. (C) Confocal
immunofluorescence detection of cells labeled with anti-b-III Tubulin and anti-GFAP antibodies shows increased expression of b-III Tubulin and GFAP
following calpain 1 knockdown and decreased expression of GFAP following calpain 2 knockdown in differentiating NS-TGFP cells. Hoechst 33258
staining was used to visualize cell nuclei. Scale bar, 10 mm.
doi:10.1371/journal.pone.0033468.g008
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inhibitor calpastatin. Briefly, cells were transfected with ,2 mg
pcDNA-Flag-mCAST construct, kindly provided by Dr. Duarte
(Center for Neuroscience and Cell Biology, Coimbra, Portugal), or
with pcDNA empty vector. The Flag-mCAST construct was
prepared by cloning full-length mouse calpastatin cDNA with N-
terminal Flag into pcDNA vector (Invitrogen Corp.). Cells were
cultured in uncoated dishes in N2B27 medium supplemented with
10 ng/mL EGF and 10 ng/mL bFGF for 24 h, transfected for 6 h
using Lipofectamine 2000 and then the medium was changed to
differentiation medium. Calpastatin overexpression was evaluated
by immunoblotting against the Flag tag.
Flow cytometry analysis
NS-TGFP cells were washed twice with Ca
2+- and Mg
2+-free
PBS (Invitrogen Corp.), treated with accutase and harvested with
PBS. MNSC were trypsinized (0.025% trypsin/EDTA) (Invitrogen
Corp.) and harvested in Ca
2+-free and Mg
2+-free PBS and 2%
FBS. For cell death analysis, cells were stained with the vital dye PI
(5 mg/mL; Sigma-Aldrich Co.) and Annexin-V-APC (eBioscience,
Inc., San Diego, CA), according to manufacturer’s instructions, to
determine phosphatidylserine exposure. Proliferation levels were
determined by BrdU incorporation analysis using the APC BrdU
Flow Kit (BD Biosciences Pharmingen, San Diego, CA). BrdU was
added to the culture medium 3 h after cell treatments, and cells
were re-incubated for additional 6 h for flow cytometry analysis.
For detection of Nestin and b-III Tubulin expression levels, cells
were fixed with paraformaldehyde (4% w/v) in PBS for 20 min at
4uC, washed twice with washing solution 0.1% saponin (Fluka,
Biochemika, Switzerland) in PBS, and blocked for 20 min in blocking
solution 0.25% saponin and 5% FBS in PBS. Subsequently, cells were
washed and incubated with antibodies reactive to Nestin (MAB 353;
Chemicon International, Temecula, CA) or b-III Tubulin (Tuj1;
Covance, Princeton, New Jersey) at a dilution of 1:300 and 1:500,
respectively, in antibodyblocking solution (0.1% saponin and 5%FBS
in PBS), for 30 min. Cells were then washed twice and incubated with
anti-mouse antibody conjugated to Dylight 649 (Jackson ImmunoR-
esearch Laboratories, Inc., West Grove, PA), at a dilution of 1:5000
for 30 min. Cells were washed twice, resuspended in PBS with 2%
FBS and analyzed using the FACSCalibur (Becton Dickinson,
Mountain View, CA). Data were statistically evaluated using FlowJo
software (Tree Star, Inc, Ashland, OR).
Immunoblotting
Steady-state levels of cyclin E, p21, p27, b-III Tubulin, GFAP,
calpain 1, calpain 2, Flag-calpastatin and b-actin were determined
by immunoblotting. Cells were collected and lysed for isolation of
total protein extracts with lysis buffer (50 mM KCl, 50 mM PIPES,
10 mM EGTA, 2 mM MgCl2, 0.5% Triton X-100, pH 7.4)
supplemented with 100 mM PMSF, 1 mM DTT and Halt Protease
and Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific Inc.,
Rockford, IL), followed by centrifugation at 200g at 4uC for 20 min.
Protein content was measured by the Bio-Rad protein assay kit (Bio-
Rad Laboratories, Hercules, CA, USA) according to the manufac-
turer’s specifications, using bovine serum albumin as standard. Fifty
to one hundred mg of total protein extracts were separated on 8%
sodium dodecyl sulphate-polyacrylamide electrophoresis gel, and
then subjected to immunoblotting using primary mouse monoclonal
antibodies reactive to p27 (Santa Cruz Biotechnology, Santa Cruz,
CA), b-III tubulin (Tuj1; Covance), GFAP (MAB360; Chemicon
International), Flag (M2; Sigma-Aldrich Co.) or b-actin (A5441;
Sigma-Aldrich Co.), or primary rabbit polyclonal antibodies reactive
to cyclin E (Santa Cruz Biotechnology), calpain 1 (sc-7531-R; Santa
Cruz Biotechnology) or calpain 2 (2539; Cell Signaling Technology,
Inc., Beverly, MA), or primary goat polyclonal antibodies reactive to
p21 (Santa Cruz Biotechnology). Blots were subsequently incubated
with secondary antibodies conjugated with horseradish peroxidase
(Bio-Rad Laboratories). Finally, membranes were processed for
proteindetection using Immobilon (MilliporeCorporation, Billerica,
MA) or SuperSignal reagent (Pierce, Rockford, IL). Ponceau S
staining was also used to assess equal gel loading.
Immunocytochemistry
For detection of proliferating cells, S-phase nuclei were stained
using the BrdU In-Situ Detection Kit (BD Biosciences Pharmingen).
BrdU was added to the culture medium 3 h after cell treatments,
and cells were re-incubated for additional 6 h and processed
according to manufacturer’s instructions. For fluorescence micros-
copy, NS-TGFP cells were fixed with paraformaldehyde (4%, w/v)
in PBS and blocked for 1 h at room temperature in PBS, containing
0.1% Triton X-100, 1% FBS, and 10% normal donkey serum
(Jackson ImmunoResearch Laboratories, Inc.). For single staining,
cells were incubated with either anti-b-III Tubulin or anti-GFAP
antibodies at a dilution of 1:1000 in blocking solution, overnight at
4uC. Cells were then incubated with an Alexa 568-conjugated anti-
mouse antibody(Life Technologies Ltd, Paisley,UK)at a dilution of
1:200 in blocking solution, for 2 h at room temperature. Mouse NS
cell nuclei were then stained with Hoechst 33258 (Sigma-Aldrich
Co.) at 50 mg/ml in PBS, for 5 min at room temperature. For co-
labeling of b-III Tubulin and GAFP, cells were incubated with
mouse anti-b-III Tubulin and rabbit anti-GFAP (Sigma-Aldrich
Co.) antibodies at a dilution of 1:500 and 1:250, respectively, in
blocking solution, overnight at 4uC. Cells were then incubated with
Alexa 405-conjugated anti-mouse and Alexa 594-conjugated anti-
rabbit antibodies (Life Technologies Ltd) at a dilution of 1:200 each,
for 2 h at room temperature. Samples were mounted using
Fluoromount-G
TM (Beckman Coulter, Inc., Brea, CA). Fluores-
cence microscopy assessments were performed with a Zeizz AX10
microscope (Carl Zeiss, Jena, Germany) equipped with a Leica
DFC490 camera (Leica Wetzlar, Germany) or with a Zeiss LSM
510 META confocal microscope (Carl Zeiss).
Densitometry and statistical analysis
The relative intensities of protein bands were analyzed using the
Quantity One Version 4.6.3 densitometric analysis program (Bio-
Rad Laboratories). Results from different groups were compared
using the Student’s t test, two-way ANOVA or one-way ANOVA
followed by Bonferroni’s or Dunnett’s multiple comparison tests.
Values of p,0.05 were considered statistically significant. All
statistical analysis was performed with GraphPad Prism 5 software
(GraphPad Software, Inc., San Diego, CA).
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